IP Library Patent Application 63559682
Patent Application Provisional
App. No. 63/559,682 · Confirmation No. 7584

RNAi Agents for Dual Inhibition of Expression of Apolipoprotein C-III (APOC3) and Proprotein Convertase Subtilisin Kexin 9 (PCSK9), Compositions Thereof, and Methods of Use

Provisional Application Expired
⬇ PDF
Code Description Pages PDF
2025-03-26 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2025-03-24 PA.. Power of Attorney 2 View
2025-03-24 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-04-23 APP.FILE.REC Filing Receipt 3 View
2024-04-23 WELCOME.LET Welcome Letter from USPTO Director and Deputy Director 1 View
2024-02-29 SPEC Specification View
2024-02-29 N417.PYMT Electronic Fee Payment 2 View
2024-02-29 TR.PROV Provisional Cover Sheet (SB16) 4 View
2024-02-29 SPEC Specification 125 View
2024-02-29 CLM Claims 9 View
2024-02-29 ABST Abstract 1 View
2024-02-29 ADS Application Data Sheet 9 View
2024-02-29 N417 Electronic Filing System Acknowledgment Receipt 2 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/559,682
Filed
2024-02-29